Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
Guardado en:
Autores principales: | Ann Taber, Emil Christensen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb71e221dff14ceab6bffe89d0363cd6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Ann Taber, et al.
Publicado: (2020) -
Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
por: Mathieu Roumiguie, et al.
Publicado: (2021) -
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Sia Viborg Lindskrog, et al.
Publicado: (2021) -
Cisplatin is retained in the cochlea indefinitely following chemotherapy
por: Andrew M. Breglio, et al.
Publicado: (2017) -
Reconciling Anti-Essentialism and Quantitative Methodology
por: Mathias Fjællegaard Jensen
Publicado: (2017)